REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Mpharm S.R.O. (Slovakia)

Main Activities: Pharmacies and Drug Stores | Department Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Advertising Agencies | Other Business Service Centers (including Copy Shops)
Full name: Mpharm S.R.O. Profile Updated: October 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Mpharm S.R.O. is an enterprise in Slovakia, with the main office in Nove Zamky. It operates in the Pharmacies and Drug Stores sector. The company was established on January 08, 2011. In 2024, the company reported a net sales revenue increase of 29.64%. During that time, Mpharm S.R.O.’s total assets grew by 12.84%. In, 2024, the company’s net profit margin increased by 1.3%.

Headquarters
Surianska, 10022/7
Nove Zamky; Nitriansky; Postal Code: 94002

Contact Details: Purchase the Mpharm S.R.O. report to view the information.

Basic Information
Registered Capital:
Purchase the Mpharm S.R.O. report to view the information.
Financial Auditors:
Purchase the Mpharm S.R.O. report to view the information.
Incorporation Date:
January 08, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Mpharm S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
29.64%▲
Total operating revenue
26.13%▲
Operating profit (EBIT)
385.38%▲
EBITDA
185.86%▲
Net Profit (Loss) for the Period
2666.38%▲
Total assets
12.84%▲
Total equity
32.9%▲
Operating Profit Margin (ROS)
1.53%▲
Net Profit Margin
1.3%▲
Return on Equity (ROE)
23.57%▲
Debt to Equity Ratio
42.47%▲
Quick Ratio
0.12%▲
Cash Ratio
0.09%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo